Indeed, upregulation of CD25 [48] and CD38 [44] expression is also observed in all differentiation stages of CD8+, Vδ1+, and Vδ2+ T lymphocytes in COVID-19 patients, except in Vδ2+ TEMRA, compared to recovered and healthy subjects [48,49]. This evidence concerns the gene CD8A and COVID-19.